Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis (Q38124282)

From Wikidata

Revision as of 10:05, 11 July 2024 by Twofivesixbot (talk | contribs) (‎Updated Item: rm P2888 pointing to scigraph.springernature.com; site discontinued and merely duplicating DOI)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on September 2013

Language	Label	Description	Also known as
English	Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis	scientific article published on September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

interstitial lung disease

1 reference

based on heuristic

inferred from title

author name string

Patrick D W Kiely

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Felix Chua

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

1 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Current Rheumatology Reports

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

359

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Interstitial pneumonitis in dermatomyositis.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Pulmonary disease in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Polymyositis-dermatomyositis-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Myositis-related interstitial lung disease and antisynthetase syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Calprotectin is released from human skeletal muscle tissue during exercise.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to signal recognition particle in polymyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary involvement in polymyositis and in dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum KL-6 in adult patients with polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial Pneumonitis in Association with Polymyositis and Dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognosis of 69 patients with dermatomyositis or polymyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/23888366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11926-013-0359-6

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38124282&oldid=2201302213"